Clinical Trial Unit

The Clinical Trial Unit of the Department of Medicine 3 at Uniklinikum Erlangen is a center for innovative therapeutic approaches within Phase I-IV clinical trials.

Our primary goal is to open new perspectives for patients with inflammatory diseases through advanced immunotherapies. We place particular emphasis on the research and application of CAR-T cells and T-cell engagers, promising strategies that combine cutting-edge science with patient-centered care to develop personalized treatment approaches.

Alongside evaluating the safety, efficacy, and immunological mechanisms of drug therapies, we also explore and analyze novel imaging techniques such as FAPI-PET-CT and micro-CT. In addition, functional assessments of the musculoskeletal system are an integral part of our work.

We collaborate closely with leading research institutions and industry partners to ensure that patients benefit early from the latest scientific advances. Our team brings together clinical expertise, scientific excellence, and a strong commitment to high-quality care to develop innovative treatment options for patients with complex diseases.

Beyond conducting clinical trials, the Clinical Trial Unit provides comprehensive ambulatory care as part of routine clinical services. This includes an infusion clinic for delivering intravenous therapies to patients with chronic conditions or specialized treatment needs. Our team provides safe, reliable, and patient-centered care in close collaboration with the attending physicians.

Through our work, we contribute significantly to the advancement of medicine and offer patients access to the therapies of tomorrow.